Global
中文
EN
About
Development milestones
Mission&Vision
Founder
Research Achievement
Technology Platforms
Single domain antibody
Five core technology platforms
Pipeline
Business cooperation
Product Out-Licensing
Co-Development
Career development
Our Story
Social Recruitment
News
Company News
Media
Contact Us
Company Address
Online Message
×
Home
中文
EN
About
About Novamab
Technology Platforms
Pipeline
Business cooperation
Market target layout
Strategic Cooperation
Career development
News
Company News
Media
Contact Us
About
Committed to the development
of innovative single domain antibody drugs
About Novamab
Scientific research papers
Up to now, the R&D team of Novamab Biology has published several research papers in influential journals.
2020-01-13
Preclinical development of a novel CD47 nanobody with less toxicity and enhanced anti-cancer therapeutic potentia
Published on:
Journal of Nanobiotechnology. 2020 Jan 13;18(1):12
More
2020-01-07
Simultaneous Unlocking Optoelectronic and Interfacial Properties of C60 for Ultrasensitive Immunosensing by Coupling to Metal-Organic Framework
Published on:
Analtical Chemistry. 2020 Jan 7;92(1):983-990
More
2019-11-05
Blocking the PD-1-PD-L1 axis by a novel PD-1 specific nanobody expressed in yeast as a potential therapeutic for immunotherapy
Published on:
Biochemical and Biophysical Research Communications. 2019 Nov 5;519(2):267-273
More
2019-10-16
Construction of Anti-hPD-L1 HCAb Nb6 and in Situ124 Labeling for Noninvasive Detection of PD-L1 Expression in Human Bone Sarcoma
Published on:
Bioconjugate Chemistry. 2019 Oct 16;30(10):2614-2623
More
2018-07-11
Direct Immunoassay for Facile and Sensitive Detection of Small Molecule Aflatoxin B1 based on Nanobody
Published on:
Chemistry: A European journal. 2018 Jul 11;24(39):9869-9876
More
2018-03-23
Boosted Electrochemical Immunosensing of Genetically Modified Crop Markers Using Nanobody and Mesoporous Carbon
Published on:
ACS Sensors. 2018 Mar 23;3(3):684-691
More
总计 24
1
2
3
4